Sorry, you need to enable JavaScript to visit this website.


Top Management

Executive Committee(as of October 2019)

The Executive Committee discusses important matters of management across Astellas. It is chaired by the Representative Director, President and CEO, and comprises top management as standing members. Extended members include the officers responsible for research, development and pharmaceutical technology capabilities together with the officers responsible for each region, and these members participate in any necessary discussions at the request of the chairman.

Standing Members

Representative Director, 
President and CEO
Kenji Yasukawa, Ph.D.
Representative Director, 
Corporate Executive Vice President, 
Chief Strategy Officer (CStO) and 
Chief Financial Officer (CFO)
Naoki Okamura
Chief Administrative Officer and 
Chief Ethics & Compliance Officer
Fumiaki Sakurai
General Counsel Linda Friedman
Chief Medical Officer Bernhardt Zeiher, M.D.
Chief Commercial Officer Yukio Matsui


Extended Members

President, Drug Discovery Research Akihiko Iwai
President, Pharmaceutical Technology Hideki Shima
President, Development Steven Benner
President, Established Markets Commercial Dirk Kosche
President, Greater China Commercial Hiroshi Hamaguchi
President, International Commercial Claus Zieler
President, Japan Commercial Nobuaki Tanaka
President, US Commercial Percival Barretto-Ko


Group Management Structure (As of April 1, 2019)

Group Management Structure